Vitamin D clinical trials show major survival benefits and decreases in ICU admission rates! This vitamin is essential for a properly functioning immune response. Why are the US and even the World Health Organization officials ignoring the science of essentials and parroting the religious mantra that a vaccine will be our “savior?”
The results of the study were astounding!
Out of 50 patients treated with calcifediol ( immediately active form of “Vit D”) only 1 required admission to the ICU (2%) with no one dying.
Of the 26 untreated patients, 13 required admission (50%) with 2 deaths (7.6%).
Of the patients treated with calcifediol, none died, and all were discharged, without complications but yet this science seems to be ignored by the medical community and the US government…Why?
Want to share a short clip of power information with a family member or friend from this show? Click here! Governments Have Ignored Science That Could have Saved the Lives of Millions.
Resources / References:
Covid: Free Vitamin D pills for 2.5 million vulnerable in England
Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis
Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data
New evidence that vitamin D prevents respiratory infections
Covid-19: Vaccine candidate may be more than 90% effective, interim results indicate
Vitamin D and the Immune System
Severe vitamin D deficiency in patients with Kawasaki disease: a potential role in the risk to develop heart vascular abnormalities?
“Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”
Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study)
Preventive Effects of Vitamin D on Seasonal Influenza A in Infants: A Multicenter, Randomized, Open, Controlled Clinical Trial
Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results
Low serum 25‐hydroxyvitamin D (25[OH]D) levels in patients hospitalised with COVID‐19 are associated with greater disease severity
25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2
Vitamin D to prevent COVID‐19: recommendations for the design of clinical trials
Immune Modulatory Effects of Vitamin D on Viral Infections